Skip to content
All insights

Insights

In a thin health IT deal market, deployed products get the attention

PitchBook data summarized by Sikich shows health IT deal activity down sharply in the first half of 2026, with buyers favoring products that are already deployed and earning recurring revenue. For founders, the people who run deployments are part of what a buyer is paying for.

Keith Anderson, Founder3 min read

Health IT is the quiet corner of a busy healthcare deal market. According to Sikich's Q3 2026 update, which draws on PitchBook data, healthcare M&A in total reached $66.5 billion in the third quarter, but health tech lagged. The more useful point for a founder is what the remaining buyers say they want.

What the data shows

Sikich reports 121 health IT deals worth $5 billion in the first half of 2026. That is down 9% in volume and 65% in value year over year. The largest was GE HealthCare's $2.3 billion purchase of Intelerad. PitchBook's healthcare technology systems group also posted a 35% three-month decline in deal count, though the summary notes that PitchBook's latest-quarter counts lag and are revised upward as deals are logged, so deal value is the cleaner measure.

Sikich says buyers are favoring acquisition targets with proven, deployed products and recurring revenue over those still selling a road map. It also reports health IT pricing of about 7.3x EV/revenue across 2025 and the first half of 2026, compared with 4.6x in 2023 and 2024, and attributes the rise to higher-growth software targets lifting the average.

What the data does not show

This is a secondary summary of PitchBook, and the full PitchBook report is not public. The figures cover health IT broadly, not any one segment. Other sources measure healthcare IT private equity differently and have described activity as strong, so definitions matter, and we are not claiming the whole market has cooled. Neither number says anything about how any single company performed in diligence.

Our interpretation

This section is interpretation, not Sikich's or PitchBook's conclusion. A buyer cannot diligence a road map. It can call customers, read implementation records, and ask who keeps the product running after go-live. In a market with fewer deals, each one gets a closer look, and the evidence that holds up best is deployment history.

That makes the people who deploy part of the asset. If the knowledge of how your product connects to a customer's systems lives in one engineer's head, a buyer will notice.

What this means for hiring

  • Name the owner of every customer launch, and make sure a second person has done one with them.
  • Hire your integration and implementation leaders before the pitch or the sale process, not during it.
  • Write down what your best implementer knows: data mappings, customer-specific workarounds, known limits.
  • Ask what would make your most critical builder leave, and fix it while it is cheap.

None of this requires a sale to be on the horizon. It makes the company easier to run today.

If you are planning an implementation, integration, or data engineering hire, we are glad to compare notes on what the role should prove.

Keith Anderson, Founder

Sources

Keith Anderson, Founder

TechStarsGroup

Connect on LinkedIn

Next step

Have a role that needs to move?

A 30 minute conversation about the role, the gap, and whether the market can support the hire you have in mind.